Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $450.68 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $151.43 | 7 | $0 (2023) |
| Madrigal Pharmaceuticals | $127.99 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $108.12 | 1 | $0 (2024) |
| ABBVIE INC. | $40.21 | 2 | $0 (2023) |
| Ardelyx, Inc. | $22.93 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $236.11 | 2 | Madrigal Pharmaceuticals ($127.99) |
| 2023 | $214.57 | 10 | Celgene Corporation ($151.43) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $127.99 | General |
| Category: LIVER DISEASE | ||||||
| 06/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $108.12 | General |
| 12/14/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.30 | General |
| Category: Neuroscience | ||||||
| 10/12/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.58 | General |
| Category: Neuroscience | ||||||
| 09/26/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $10.49 | General |
| Category: Neuroscience | ||||||
| 08/31/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.83 | General |
| Category: Neuroscience | ||||||
| 07/25/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.93 | General |
| Category: Neuroscience | ||||||
| 06/01/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.57 | General |
| Category: Neuroscience | ||||||
| 05/30/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/04/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.73 | General |
| Category: Neuroscience | ||||||
| 03/30/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 22 | 22 | $6,116 | $1,967 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $6,116 | $1,967 | 32.2% |
About Grace Lo
Grace Lo is a Physician Assistant healthcare provider based in Pasadena, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2021. The National Provider Identifier (NPI) number assigned to this provider is 1174286181.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Grace Lo has received a total of $450.68 in payments from pharmaceutical and medical device companies, with $236.11 received in 2024. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($450.68).
As a Medicare-enrolled provider, Lo has provided services to 22 Medicare beneficiaries, totaling 22 services with total Medicare billing of $1,967. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Pasadena, TX
- Active Since 10/17/2021
- Last Updated 08/13/2024
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1174286181
Products in Payments
- ZEPOSIA (Drug) $151.43
- REZDIFFRA (Drug) $127.99
- IBSRELA (Drug) $22.93
- VIBERZI (Drug) $20.80
- LINZESS (Drug) $19.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Pasadena
Nour Shahab, Pa-C, PA-C
Physician Assistant — Payments: $14,099
Thuy Hua, Pa-C, PA-C
Physician Assistant — Payments: $10,130
Mrs. Iman Jomaa
Physician Assistant — Payments: $7,726
Julia Berman
Physician Assistant — Payments: $5,989
Ms. Jessica Hanson, Pa-C, PA-C
Physician Assistant — Payments: $4,951
Carlitos Chen
Physician Assistant — Payments: $4,613